文献速递腹部介入外周血管DSACT

术后DSA肝内分支通畅性预测非肝硬化门静脉血栓再通预后

Final Postprocedural DSA Intrahepatic Branch Patency Predicts Outcomes After Endovascular Recanalization for Acute Non-cirrhotic Portal Vein Thrombosis.
PubMed 文献 · Acad Radiol · 2026-07-08

回顾性纳入122例急性非肝硬化门静脉血栓接受血管内再通患者,根据术后DSA肝内分支是否通畅分组。结果显示肝内分支闭塞组住院期间肠坏死、消化道出血及随访腹痛复发、门静脉海绵样变性、二次干预率更高。多因素Cox分析提示肝内分支闭塞与症状复发独立相关。

要点

  • 术后DSA显示肝内分支闭塞者不良事件和症状复发风险更高
  • 肝内分支闭塞伴TIPS与随访消化道出血更少相关
  • 肝内分支通畅性可辅助制定随访与个体化管理策略

核心结论

  • 术后DSA肝内分支通畅性可为非肝硬化门静脉血栓血管内再通后提供预后信息
  • 持续肝内分支闭塞提示不良结局风险增高并支持加强随访与个体化管理

研究设计与样本

  • 回顾性研究纳入122例接受血管内再通的急性非肝硬化门静脉血栓患者
  • 根据术后DSA结果将患者分为肝内分支通畅组和闭塞组
  • 比较早期术后结局、随访不良事件、总生存与支架通畅性
  • 采用Kaplan-Meier和Cox回归分析与症状复发相关的因素

关键影像表现/征象

  • 术后DSA显示肝内分支通畅71例,闭塞51例
  • 闭塞组随访门静脉海绵样变性比例更高
  • 随访支架闭塞发生于49例有随访资料患者中的35例

诊断标准与关键数值

  • 闭塞组住院期间肠坏死率17.6%,通畅组4.2%(P=0.014)
  • 闭塞组消化道出血率35.7%,通畅组7.9%(P<0.001)
  • 闭塞组随访腹痛复发率78.6%,通畅组30.2%(P<0.001)
  • 闭塞组门静脉海绵样变性率92.9%,通畅组65.1%(P=0.001)
  • 闭塞组二次干预率52.4%,通畅组22.2%(P=0.002)

临床应用与阅片要点

  • 术后DSA应重点判读肝内门静脉分支是否通畅
  • 发现肝内分支闭塞时应考虑加强随访并警惕腹痛复发与消化道出血
  • 肝内分支闭塞合并TIPS可能减少随访消化道出血风险
  • 总生存组间无显著差异,评估时需结合症状事件综合判断

局限性

  • 回顾性研究
  • 部分患者缺乏随访支架通畅性资料
  • 总生存组间未显示显著差异

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate whether intrahepatic branch patency on postprocedural digital subtraction angiography (DSA) predicts outcomes after endovascular recanalization for non-cirrhotic portal vein thrombosis (NCPVT).

MATERIALS AND METHODS: This retrospective study included 122 patients with acute NCPVT who underwent endovascular recanalization. According to final postprocedural DSA findings, patients were classified into patent and occluded intrahepatic branch groups. Early postprocedural outcomes, follow-up adverse events, overall survival, and stent patency were compared. Kaplan-Meier and Cox regression analyses were used to identify factors associated with symptom recurrence.

RESULTS: Postprocedural DSA demonstrated patent intrahepatic branches in 71 patients and occlusion in 51. Compared with the patent group, the occluded group had higher rates of bowel necrosis during hospitalization (17.6% vs 4.2%, P = 0.014), gastrointestinal bleeding (35.7% vs 7.9%, P < 0.001), recurrent abdominal pain (78.6% vs 30.2%, P < 0.001), cavernous transformation of the portal vein (CTPV) (92.9% vs 65.1%, P = 0.001), and secondary intervention (52.4% vs 22.2%, P = 0.002) during follow-up. In multivariable Cox analysis, intrahepatic branch occlusion remained independently associated with symptom recurrence (hazard ratio, 3.08; 95% confidence interval, 1.57-6.03; P = 0.001). Overall survival did not differ significantly between groups. Transjugular intrahepatic portosystemic shunt (TIPS) was not independently associated with overall symptom recurrence, although in patients with intrahepatic branch occlusion it was associated with less gastrointestinal bleeding during follow-up. Stent occlusion occurred in 35 of 49 patients with available follow-up data.

CONCLUSION: Intrahepatic branch patency on postprocedural DSA provides prognostic information after endovascular recanalization for NCPVT. Persistent branch occlusion identifies patients at increased risk for adverse outcomes and may support closer surveillance and individualized postprocedural management.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Xue, Guo, Hua, et al. Final Postprocedural DSA Intrahepatic Branch Patency Predicts Outcomes After Endovascular Recanalization for Acute Non-cirrhotic Portal Vein Thrombosis. Acad Radiol. 2026. PMID: 42420144. doi:10.1016/j.acra.2026.06.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。